Anzeige
Mehr »
Mittwoch, 07.01.2026 - Börsentäglich über 12.000 News
Das Wildwest-Silberrevier, das bei 80-Dollar-Silber wichtiger ist denn je!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41XT7 | ISIN: KYG4790P1037 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
INSILICO MEDICINE CAYMAN TOPCO Chart 1 Jahr
5-Tage-Chart
INSILICO MEDICINE CAYMAN TOPCO 5-Tage-Chart

Aktuelle News zur INSILICO MEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoInsilico adds Sanofi to partnership roster with $888m deal20
MoInsilico and Servier announce $888m oncology research agreement2
MoInSilico Signs US$888Mln Multi-Year Oncology Drug Discovery Deal With Servier5
MoInsilico Medicine And Servier Announce Up To $888 Million Multi-Year Oncology Drug Discovery Collaboration2
MoInsilico Medicine Announces US$888 Mln Multi-Year Oncology Collaboration With Servier-
MoInsilico Medicine Announce US$888 Million Multi-Year Collaboration with Servier for Drug Discovery and Development in Oncology85Insilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and developing innovative oncology therapies...
► Artikel lesen
MoINSILICO (03696): VOLUNTARY ANNOUNCEMENT ON MULTI-YEAR COLLABORATION WITH SERVIER FOR DRUG DISCOVERY AND DEVELOPMENT IN ONCOLOGY4
INSILICO MEDICINE Aktie jetzt für 0€ handeln
31.12.25Insilico ends 2025 with $293m Hong Kong IPO2
31.12.25Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange416SHANGHAI, Dec. 31, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed...
► Artikel lesen
30.12.25AI Drug Discovery Unicorn Insilico Medicine Jumps In Hong Kong Trading Debut2
30.12.25Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO331HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully...
► Artikel lesen
30.12.25INSILICO Closes Up 24.7% to $29.981
30.12.25BRIEF: InSilico jumps in Hong Kong trading debut1
30.12.25INSILICO Closes Up 34.1% to $32.26 at Midday1
30.12.25INSILICO Opens Up 45.5% to $35 on Debut2
29.12.25INSILICO (03696): ANNOUNCEMENT OF ALLOTMENT RESULTS1
29.12.25InSilico Medicine Closes Up 53.3% to $36.86 on Gray Mkt2
29.12.25InSilico Medicine Opens Up 70.5% to $41 on Gray Mkt3
18.12.25AI-Driven Drugmaker INSILICO's IPO Starts Tdy; Eli Lilly/TENCENT/Temasek Among Cornerstone Investors6
17.12.25INSILICO (03696): GLOBAL OFFERING1
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1